Skip to content

Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-08

Recalling firm: ProRx LLC
Origin: PA, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-0116-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Semaglutide recalls

Class II · Moderate risk Ongoing Jul 29, 2026

SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO…

Reason Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Apollo Care, LLC NDC 71170-724-04 D-0757-2026

Class II · Moderate risk Ongoing Jul 29, 2026

SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO…

Reason Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Apollo Care, LLC NDC 71170-722-02 D-0756-2026

Class II · Moderate risk Ongoing Jul 29, 2026

SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only…

Reason Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Apollo Care, LLC NDC 71170-721-01 D-0755-2026

Class II · Moderate risk Ongoing Jul 29, 2026

SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO…

Reason Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Apollo Care, LLC NDC 71170-712-03 D-0754-2026

Class II · Moderate risk Ongoing Jul 29, 2026

SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only…

Reason Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Apollo Care, LLC NDC 71170-711-02 D-0753-2026